|
|
735 Yeoksam 1-dong, Gangnam-gu
Seoul, South Korea 135 755 South Korea
phone:
fax:
|
|
| Symbol |
|
| Exchange |
|
| Founded |
0 |
| Employees |
|
|
|
| www.handok.co.kr/
|
|
|
|
 |
| Summary Description |
| Internationally recognized leader in the pharmaceutical industry. |
|
| Management |
| Young-Jin Kim, Chief Executive Officer |
| |
|
|
|
|
|
| Keywords |
| pharmaceuticals, drugs, diabetes, gastroenterology, dermatology, allergy, urology |
|
|
|
| Description |
|
HANDOK Pharmaceuticals Co., Ltd., (002390 KS), based in Seoul Korea, is a company posting 275B KRW in pharmaceutical, diagnostic, and OTC sales in 2008. HANDOK is among ten domestic companies in Korea and it has never recorded a deficit year since its establishment. HANDOK, founded in 1954, is the pharmaceutical company in Korea with the most successful track records in various types of partnerships. It formed a JV with Hoechst in 1964, which led to the current strategic partnership with sanofi-aventis in Korea and, moreover, have 20 other partners focusing on innovative products, including CSL, Solvay, Actelion, and AEterna Zentaris among others. HANDOK is the leader in diabetes treatment in Korea. It is also known to have leading expertise in various therapeutic categories including CV, Urology and respiratory system as well as to strive to get into oncology and CNS areas in the future. HANDOK maintains a world class GMP manufacturing facility and was the first local Korean company to incorporate clinical research capabilities with medical directors on staff. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members